๐ฐ Chief Restructuring News
Page 2 - Chief Restructuring News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Chief Restructuring. Real-time updates on events, politics, business and more.
February 7, 2024
Progeny has announced the appointment of Tom Wood as its new Chief Financial Officer (CFO). Wood brings a wealth of experience to his new role, with a background spanning 25 years in regulated financial services and banking. His career highlights include serving as the Chief Restructuring and Financial Officer of the
February 7, 2024
Good morning and welcome to your Morning Briefing for Wednesday 7 February 2024. To get this in your inbox every morning click here. Progeny appoints Tom Wood as new CFO Progeny has announced the appointment of Tom Wood as its new Chief Financial Officer (CFO). Wood brings a wealth of experience to his new role, with
January 30, 2024
Agencies fine Amazon for โexcessivelyย intrusiveโ warehouse labor software, block acquisition of iRobot
January 24, 2024
MedMen Enterprises Inc. , a premier cannabis company, today announced that Ellen Deutsch Harrison has stepped down as the Chief Executive Officer and a Board member effective January 19, 2024 and...
January 10, 2024
Canadian Overseas Petroleum Ltd Announces Update in Response to Shareholder ...
January 10, 2024
Investegate announcements from Update in Response to Shareholder Queries
January 2, 2024
COPL Announces US$2.5 Million Equity Financing, Execution of Forbearance Agreement with Senior Lender and Appointment of Chief Restructuring OfficerTHIS ANNOUNCEMENT AND THE INFORMATION CONTAINED...
December 30, 2023
Akumin Inc. announced that its Board of Directors has appointed Ronald J. Bienias, Akumins Chief Restructuring Officer and Partner and Managing Director of AlixPartners, LLP, as Interim Chief...
December 30, 2023
PLANTATION, Fla., Dec. 29, 2023 /CNW/ - Akumin Inc. announced today that its Board of Directors has appointed Ronald J. Bienias, Akumins Chief Restructuring Officer and Partner and Managing...
December 20, 2023
/PRNewswire/ -- Impel Pharmaceuticals Inc. (OTCQX: IMPL) ("Impel" or "the Company"), a commercial-stage biopharmaceutical company with a mission to develop...